Charles River Laboratories has grown revenue −1.5% a year over three years and 4.1% a year over five. Revenue growth, 3-year annual rate: −1.5% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +4.1%, growth has slowed since the five-year average. Years of annual history on file: 18, FY2008 to FY2025, as filed.

CRLCharles River Laboratories

HealthcareUSD

$295.01

$145.5752 weeks$298.56

Is it growing?

Is CRL growing?

Charles River Laboratories has grown revenue −1.5% a year over three years and 4.1% a year over five.

−1.5%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +4.1%
Revenue growth, 5-year rate · −1.5% over three · growth has slowed since the five-year average
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed

Details›